What is the address of PHARMIMMO BRUYÈRE?

The registered office of PHARMIMMO BRUYÈRE is located at Rue d'Hurtebise(BIN) 47, 7130 Binche.

Is PHARMIMMO BRUYÈRE still active?

Yes. According to the CBE (31 October 2026) PHARMIMMO BRUYÈRE is active, legal situation “Normale toestand”, started on 3 June 1991.

Is PHARMIMMO BRUYÈRE registered on Peppol?

Yes, PHARMIMMO BRUYÈRE is registered on the Peppol network with ID 0208:0444351654.

What is the enterprise number of PHARMIMMO BRUYÈRE?

The enterprise number of PHARMIMMO BRUYÈRE is BE0444351654.

When was PHARMIMMO BRUYÈRE founded?

PHARMIMMO BRUYÈRE was founded on 3 June 1991.

Who are the directors of PHARMIMMO BRUYÈRE?

According to the 2025 annual accounts, the directors of PHARMIMMO BRUYÈRE are: Anne-Catherine Navez, LUC BRUYERE.

Is PHARMIMMO BRUYÈRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 June 1991; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMIMMO BRUYÈRE make in 2025?

PHARMIMMO BRUYÈRE recorded a loss after taxes of € 9,518 in financial year 2025.

What is the revenue of PHARMIMMO BRUYÈRE?

As a small company, PHARMIMMO BRUYÈRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 21,241.

PHARMIMMO BRUYÈRE (Private Limited) - Binche

Dossier PHARMIMMO BRUYÈRE, printed on 31 October 2026 from databakkes.be/en/0444351654/pharmimmo-bruyere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMIMMO BRUYÈRE from Binche, company number BE0444351654, closed financial year 2025 with a result of € -9,518 after tax. For that financial year PHARMIMMO BRUYÈRE recorded a gross margin of € 21,241 and equity of € 951,079. Compared with financial year 2024, the result moved from € 203,014 to € -9,518. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Healthy

€ 951,079

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -9,518

▼ still € 203,014 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 169,449

▼ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 932,479.

People and assets in 2025

Vehicles and equipment

€ 6,769

▼ 66% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 6,976

▼ 61% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 297,208 Gross margin 2022: € 297,208 First fiscal year in the series	€ 293,932 Gross margin 2023: € 293,932 ▼ 1% vs 2022 (€ 297,208) Unfavourable step	€ 346,542 Gross margin 2024: € 346,542 ▲ 18% vs 2023 (€ 293,932) Favourable step	€ 21,241 Gross margin 2025: € 21,241 ▼ 94% vs 2024 (€ 346,542) Unfavourable step	▼ 94%
Profit after taxes	€ 146,313 Profit after taxes 2022: € 146,313 First fiscal year in the series	€ 142,433 Profit after taxes 2023: € 142,433 ▼ 3% vs 2022 (€ 146,313) Unfavourable step	€ 203,014 Profit after taxes 2024: € 203,014 ▲ 43% vs 2023 (€ 142,433) Favourable step	€ -9,518 Profit after taxes 2025: € -9,518 ▼ € 212,533 vs 2024 (€ 203,014) Unfavourable step	▼ € 212,533
Equity	€ 918,810 Equity 2022: € 918,810 First fiscal year in the series	€ 757,582 Equity 2023: € 757,582 ▼ 18% vs 2022 (€ 918,810) Unfavourable step	€ 960,597 Equity 2024: € 960,597 ▲ 27% vs 2023 (€ 757,582) Favourable step	€ 951,079 Equity 2025: € 951,079 ▼ 1% vs 2024 (€ 960,597) Unfavourable step	▼ 1%
Total debts	€ 219,891 Total debts 2022: € 219,891 First fiscal year in the series	€ 215,700 Total debts 2023: € 215,700 ▼ 2% vs 2022 (€ 219,891) Favourable step	€ 126,133 Total debts 2024: € 126,133 ▼ 42% vs 2023 (€ 215,700) Favourable step	€ 86,898 Total debts 2025: € 86,898 ▼ 31% vs 2024 (€ 126,133) Favourable step	▼ 31%
Cash	€ 693,816 Cash 2022: € 693,816 First fiscal year in the series	€ 547,775 Cash 2023: € 547,775 ▼ 21% vs 2022 (€ 693,816) Unfavourable step	€ 241,976 Cash 2024: € 241,976 ▼ 56% vs 2023 (€ 547,775) Unfavourable step	€ 169,449 Cash 2025: € 169,449 ▼ 30% vs 2024 (€ 241,976) Unfavourable step	▼ 30%
Land & buildings	€ 116,785 Land & buildings 2022: € 116,785 First fiscal year in the series	€ 101,242 Land & buildings 2023: € 101,242 ▼ 13% vs 2022 (€ 116,785) Unchanged	€ 83,552 Land & buildings 2024: € 83,552 ▼ 17% vs 2023 (€ 101,242) Unchanged	€ 68,895 Land & buildings 2025: € 68,895 ▼ 18% vs 2024 (€ 83,552) Unchanged	▼ 18%
Retained profit	€ 868,810 Retained profit 2022: € 868,810 First fiscal year in the series	€ 738,982 Retained profit 2023: € 738,982 ▼ 15% vs 2022 (€ 868,810) Unfavourable step	€ 941,997 Retained profit 2024: € 941,997 ▲ 27% vs 2023 (€ 738,982) Favourable step	€ 932,479 Retained profit 2025: € 932,479 ▼ 1% vs 2024 (€ 941,997) Unfavourable step	▼ 1%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 272,260 Dividend 2023: € 272,260 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 272,260) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,138,701 Balance sheet total 2022: € 1,138,701 First fiscal year in the series	€ 973,282 Balance sheet total 2023: € 973,282 ▼ 15% vs 2022 (€ 1,138,701) Unchanged	€ 1,086,730 Balance sheet total 2024: € 1,086,730 ▲ 12% vs 2023 (€ 973,282) Unchanged	€ 1,037,977 Balance sheet total 2025: € 1,037,977 ▼ 4% vs 2024 (€ 1,086,730) Unchanged	▼ 4%
Employees (FTE)	-	0.8 Employees (FTE) 2023: 0.8 First fiscal year in the series	-	-

Key figures of PHARMIMMO BRUYÈRE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMIMMO BRUYÈRE?

What happened at PHARMIMMO BRUYÈRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: loss of € 9,518 (▼ € 212,533 vs 2024). filed late Source: NBB ↗
Jun 26, 1991 New establishment in La Louvière. KBO
1991 Anne-Catherine Navez became a director. NBB
1991 LUC BRUYERE became a director. NBB
Jun 3, 1991 Start of the company according to the CBE. KBO

In short

From € 146,313 profit in 2022 to € 9,518 loss in 2025.

Paid € 221,856 in corporate taxes since 2022.

Best year ever: 2024, with € 203,014 profit.

Paid out € 272,260 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Anne-Catherine Navez LUC BRUYERE

PHARMACIE DE SAINT-VAAST

PHARMIMMO BRUYÈRE

Behind PHARMIMMO BRUYÈRE are Anne-Catherine Navez and LUC BRUYERE. The same people are also behind PHARMACIE DE SAINT-VAAST.

Directors

According to the 2025 annual accounts

Anne-Catherine Navez

Manager

Also active at: PHARMACIE DE SAINT-VAAST

since 1991

LUC BRUYERE

Manager

Also active at: PHARMACIE DE SAINT-VAAST

since 1991

Establishments

Establishment units

Physical locations of this company

Registered office

Rue d'Hurtebise(BIN) 47

7130 Binche

2.053.236.513

Rue Omer Thiriar(S-V) 2

7100 La Louvière

Active since 26 June 1991

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0444.351.654
VAT number: BE 0444.351.654
Registered office: Rue d'Hurtebise(BIN) 47, 7130 Binche
Names & denominations: PHARMIMMO BRUYÈRE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 June 1991
Peppol: Active · Active since 9 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗